Please login to the form below

Not currently logged in

People, February, 2009

Recent high-profile moves in the pharmaceutical and healthcare industries Mover of the month is James Read who has joined US-based Gilead Sciences as public affairs director, international

Mover of the month

Jame Read 

James Read has joined US-based Gilead Sciences as public affairs director, international, reporting to Gilead's California headquarters. Previously, he was PR director of AstraZeneca's global marketing organisation in Wilmington, Delaware. In his new role he handles lead public and stakeholder relations, media strategy and communication, and supports internal communications across countries outside North America. He works across Gilead's franchises including HIV brands and the antifungal Ambisome and supports an R&D pipeline in HIV, respiratory and cardiovascular disease. 


Sophie Taylor-Roberts Sophie Taylor-Roberts has joined Red Health, from Beattie Communications, as an associate director. She will report to board director, Pat Pearson, head of Red Health, and will be working for clients Pfizer, Novartis Oncology and Bial.

The Foundry has recruited Julie Linforth as new business director. Former FMCG consultant and senior marketing manager, Julie has run her own business since 2001 and worked at senior level within the healthcare and FMCG sectors.

Julie Linforth


Paul Burden

Paul Burden has joined The Remedy, the London-based medical education arm at Fleishman-Hillard, as new business development director, from his previous role at Mylan Europe. He will focus on the strategic development of The Remedy, identifying and capitalising on new business opportunities with new and existing clients. Paul has 10 years' experience in pharmaceutical marketing and has led pan-European pre- and post-launch marketing projects in asthma and chronic obstructive pulmonary disease (COPD).

Qualified pharmacist and health economist, Lance Richard, is the new director of GfK HealthCare's Market Access Centre in London, and will be responsible for growing client awareness of GfK HealthCare's market access brand. He joins the company from UCB, where he was senior health economist in the global health outcomes research group, and prior to this, he worked in a market access consultancy.

Lance Richard
Sara, Uma and Sophie Lane Earl Cox has taken on three new members of staff in the account handling department. Sara Baynes, account director, joins from PAN Advertising where she managed key accounts across therapy areas. Previously, she was a product manager at Servier and at Organon. Sophie Gibbs also joins from PAN where she worked on brands used in allergic rhinitis, COPD and Parkinson's, in the UK and internationally. Uma Thaker, previously at Paling Walters, has worked extensively in scientific research for organisations such as Argenta Discovery, GlaxoSmithKline and the NHS. The new appointees will be working across the company's allergy, epilepsy, OAB and HIV brands.


Zaicom MMC, part of the Zaicom International group of companies has appointed Duane Lacey as client services manager. Duane, who brings over 10 years' pharmaceutical experience across Rx, OTC and consumer healthcare brands, will be responsible for stimulating agency business growth in the market place. Duane's experience has been gained through a combination of sales and marketing roles and he has handled both B2B and B2C channels.

Duane Lacey

Adrian Parr Adrian Parr joins healthcare advertising agency, Torre Lazur McCann London, as creative director from Paling Walters London, where he was creative director. Adrian has won Rx gold for the last four years and Epica awards for the past seven years. Prior to Paling Walters, he spent four years at Healthworld. 


Effective February 1, 2009, Stephen W Sanger will take up a position on Pfizer's board of directors in the US. Stephen was chairman of General Mills from 1995 until his retirement in 2008. He joined General Mills in 1974 and gained increasing responsibility in marketing management across the company's consumer food businesses. He was elected to General Mills' board of directors in 1992, became president in 1993, and was chief executive officer from 1995 until 2007. He began his career at Procter & Gamble in 1970. Currently a director of Target Corporation and Wells Fargo & Co, and a member of the board of the Guthrie Theatre in Minneapolis, Minnesota, Stephen is a member of the Business Council and the US Advisory Committee for Trade Policy and Negotiations. He holds a bachelor's degree in history from DePauw University and an MBA from the University of Michigan.

The Medicines and Healthcare products Regulatory Agency (MHRA) and the Appointments Commission have a new chairman of the Committee on the Safety of Devices. Dr EJ Perrins BSc MD FRCP FACC, a consultant cardiologist in Leeds, has much experience of cardiac devices and procedures and starts in the post from April. Dr Perrins qualified with honours from Leeds University in 1975. His postgraduate training was at the Hammersmith and Westminster Hospitals and the National Heart Hospital in London, and in 1985 he was appointed consultant cardiologist at the General Infirmary at Leeds. He has published widely in the fields of cardiac pacing and coronary intervention.

Dr Erika Nemeth has been appointed operations manager of Synexus Hungary and will be responsible for day-to-day management of the Synexus site in Budapest. Erika joins Synexus from Sandoz Hungaria where she was a key account manager for the oncology division. She has 14 years' experience in the pharmaceutical field, and has been involved in business development and marketing. She holds a Cum Laude medical degree from Semmelweis University, Budapest. 

IDIS has appointed Andrew Moody as marketing director to oversee the company's global marketing. He will manage IDIS' strategic and marketing functions, focusing on strategic planning, marketing positioning and brand lifecycle management. Based at IDIS' UK global headquarters, he will also lead the company's marketing team in planning processes, communication and new product development initiatives. Moody comes to IDIS from Boehringer Ingelheim, where he led  its planning, medical and regulatory teams to develop and build brand business. Prior to that, he worked for GlaxoSmithKline and Glaxo Wellcome. 

Huntsworth Health has appointed Matthew Baker client services director in the company's new office in Basel, Switzerland. Matthew previously headed the company's advertising division in Marlow, Buckinghamshire. He will drive strategic consultancy and client services for key European clients.

Sarah Avent has joined Athena Medical PR in London, as senior account executive, bringing seven years' experience of working in healthcare marketing and PR for the National Blood Service and NHS Trusts. Sarah was recently at Buckinghamshire Primary Care Trust, where she gained extensive experience in website development, media relations and project management, as well as in dealing with NHS services and health improvement initiatives. While with the National Blood Service, Sarah was involved in increasing the number of people registered on the British Bone Marrow Register, which exceeded government targets.

Cegedim Strategic Data UK has made several new appointments. Stephan Gresoviac has joined as UK business unit manager. He has a background in medical research and has spent the last three years as director of international market research for a French agency. Louise Warne joins the client service team as research executive, working primarily on PMR. Previously she was at Insight, working on primary research studies. Denham Lansdell has rejoined as research manager, working on primary market research and CSD promotion data. Denham was previously client service manager with Cegedim.

Apodi has appointed Mark Murphy as business unit director, HR. Mark joins the Berkshire–based company with over 22 years' experience as a commercially-focused senior human resource professional with broad industry experience. During the past 10 years, he has sat on the boards of NETg and Quintiles Innovex and, most recently, he was a founding partner of The Portland Partnership. He is a Fellow of both the CIPD and the ILM and is a member of the Institute of Directors.

Related links

FAQ: How do I get my move listed?


Subscribe to our email news alerts


Add my company
Red Thread Market Access Ltd

Blending brilliant writing with in-depth market access and reimbursement expertise...

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....